BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Endocrinology

Mentice receives order of total SEK 7.0 million from ABBOTT

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has...

October 19, 2021 | News

FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia

"Today's action marks the first FDA approval of a therapy to treat this very rare and devastating disease in children," said Peter Marks, M.D., Ph.D.,...

October 11, 2021 | News

Indonesia Bring New Hope to Women With Endometriosis

Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today ...

October 07, 2021 | News

Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market Mirum P...

September 23, 2021 | News

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy...

September 17, 2021 | News

Everest to support future development and commercialization globally for the treatment of renal diseases

Collaboration consolidates Everest's leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $5...

September 17, 2021 | News

Abbott to treat minimally invasive patients with aortic valve disease

The catheter aortic valve implantation (TAVI) procedure treats people with severe and symptomatic aortic snoosis whose surgical risk is considered high or ...

September 03, 2021 | News

Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment fo...

August 31, 2021 | News

HUAWEI, Aligns With PLANO to Tackle the Global Problem of Myopia

Huawei Technologies Co. Ltd. (hereinafter, Huawei) and Plano Pte. Ltd. (hereinafter, Plano) today announced their partnership to address the global problem...

August 05, 2021 | News

Journal of Asian Pacific Society of Cardiology Launches and Welcomes Submissions

Led by Dr Yeo Khung Keong (National Heart Centre Singapore, Singapore) as Editor-in-Chief, and supported by Deputy Editors, Prof.&...

August 02, 2021 | News

Beckman Coulter to Distribute BNP Cardiac Assay to Customers

Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all...

July 26, 2021 | News

Aurion Biotech Announces IOTA Cell Therapy Trial

-Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced...

July 26, 2021 | News

Implicity to provide ultra-modern heart failure solution

Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the company is expanding its line of produ...

July 23, 2021 | News

Olympus to Support Endoscopic AI Diagnosis Education for Doctors in Thailand

Japan-based Olympus Corporation took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of Internal Affairs and Com...

July 22, 2021 | News

Stay Connected